statistical significance

ICMR Study: Are There Benefits To Mixing Covaxin and Covishield?

Four Months After Itolizumab ‘Trial’ and 9 Million Infections Later – No Progress

Itolizumab for COVID-19: Who Benefits When the Drug Regulator Is Opaque?

Is Biocon’s Itolizumab Good News? Hard to Tell, Thanks to the Bad Science.

What a New Study Says About Hydroxychloroquine v. COVID-19 – a Visual Summary

p-value, asymptotic significance, statistical hypothesis testing, statistical significance, null hypothesis, probability, statistical modelling, Andrew Gelman, American Statistical Association, John Ioannidis, replication crisis, psychology replication crisis, prestigious journals,

Why the Way We Use Statistical Significance Has Created a Crisis in Science

A Similar Anomaly Has Showed up in Three Physics Experiments Since 2009. What’s Happening?